Edition:
United States

Medrx Co Ltd (4586.T)

4586.T on Tokyo Stock Exchange

1,051JPY
17 Nov 2017
Change (% chg)

¥10 (+0.96%)
Prev Close
¥1,041
Open
¥1,041
Day's High
¥1,120
Day's Low
¥1,031
Volume
569,300
Avg. Vol
531,557
52-wk High
¥1,465
52-wk Low
¥449

Latest Key Developments (Source: Significant Developments)

Medrx commences additional trial of phase I clinical trial for MRX-4TZT
Thursday, 31 Aug 2017 11:36pm EDT 

Sept 1 (Reuters) - Medrx Co Ltd <4586.T>:Says it commences additional trial of phase I clinical trial for spastic paralysis treatment plasters(MRX-4TZT) in U.S..  Full Article

Medrx signs drug development and sale contract with Cipla USA Inc
Thursday, 6 Apr 2017 02:29am EDT 

Medrx Co Ltd <4586.T> :Says the company enters into a license contract with an India-based pharma Cipla Ltd's wholly owned US-based unit Cipla USA Inc, on development and sale of MRX-4TZT, transdermal patch for the treatment of spastic paralysis.  Full Article

Medrx appoints Yonehiro Matsumura as new president, Masayoshi Matsumura as new chairman
Friday, 10 Mar 2017 01:00am EST 

Medrx Co Ltd <4586.T>: Says it appoints Yonehiro Matsumura as new president to succeed Masayoshi Matsumura . Says it appoints Masayoshi Matsumura as new chairman of the board .Says the effective date is March 24.  Full Article

Medrx receives patent for microneedle array in US
Wednesday, 22 Feb 2017 01:17am EST 

Medrx Co Ltd <4586.T>: Says the co received patent for its technology of microneedle array from United States Patent and Trademark Office .Says the patent valid till 2031.  Full Article

Medrx receives notice on patent assessment for microneedles and microneedle arrays in China
Wednesday, 28 Sep 2016 10:10pm EDT 

Medrx Co Ltd <4586.T> :Says it receives notice from State Intellectual Property Office on patent assessment for microneedles and microneedle arrays in China.  Full Article

Medrx issues bonds worth 631.8 mln yen
Thursday, 30 Jun 2016 02:00am EDT 

Medrx <4586.T>: Says payment is completed for the bonds worth 631.8 million yen .Says it has also issued 120 11th and 40 12th series options.  Full Article

Medrx to issue convertible bonds with warrants to raise 631.8 mln yen
Tuesday, 14 Jun 2016 04:45am EDT 

Medrx Co Ltd <4586.T>: Says it to issue 1st unsecured convertible bonds with warrants and to raise 631.8 million yen in total via private placement on June 30 .Says conversion price of 1,053 yen per share.  Full Article

Medrx announces phase I clinical trials result of MRX-5LBT in US
Monday, 30 May 2016 02:21am EDT 

Medrx Co Ltd <4586.T> : Says the clinical trials for MRX-5LBT have started in the United States . Says MRX-5LBT is a new type of medication that uses the ILTS® (Ionic Liquid Transdermal System), an exclusive MEDRx technology that incorporates the company’s ionic liquid expertise .Says the phase I clinical trials result shows that MRX-5LBT is more permeable for lidocaine in hypodermis than Lidoderm.  Full Article

MEDRx to receive subsidy of up to 10 mln yen
Thursday, 7 Apr 2016 03:00am EDT 

MEDRx Co Ltd:Says to receive subsidy of up to 10 mln yen from New Energy and Industrial Technology Development Organization (NEDO) for research and development expense.  Full Article

MEDRx announces exercise of options
Tuesday, 5 Apr 2016 02:00am EDT 

MEDRx Co Ltd:Says 525,000 8th series options were exercised to 525,000 shares of its common stock in April.  Full Article

BRIEF-Medrx commences phase I clinical trial for MRX-1OXT in U.S.

* Says it commenced phase I clinical trial for MRX-1OXT (oxycodone tape reagent) in the United States